We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+1.43%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$632M
AUM Growth
-$223M
(-26%)
Cap. Flow
-$201M
Cap. Flow
% of AUM
-31.75%
Top 10 Holdings %
Top 10 Hldgs %
7.73%
Holding
416
New
106
Increased
49
Reduced
134
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lipocine
LPCN
|
+$4.68M |
| 2 |
LGI Homes
LGIH
|
+$4.16M |
| 3 |
Kforce
KFRC
|
+$4.03M |
| 4 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$3.32M |
| 5 |
Euronet Worldwide
EEFT
|
+$3.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIGM
Sigma Designs Inc
SIGM
|
+$8.78M |
| 2 |
TG Therapeutics
TGTX
|
+$6.81M |
| 3 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
+$5.56M |
| 4 |
ECHO
Echo Global Logistics, Inc.
ECHO
|
+$5.1M |
| 5 |
Boot Barn
BOOT
|
+$4.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.59% |
| 2 | Technology | 20.66% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Industrials | 10.33% |
| 5 | Financials | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Axcelis
ACLS
$4.27B
| $857K | 0.14% |
80,218
-25,619
| -24% | -$312K |
|
|
SREV
277
DELISTED
ServiceSource International, Inc.
SREV
| $838K | 0.13% |
+209,479
| New | +$1.05M |
|
|
TVRD
278
Tvardi Therapeutics
TVRD
$18.8M
| $794K | 0.13% |
+1,543
| New | +$1.03M |
|
|
AMED
279
DELISTED
Amedisys
AMED
| $769K | 0.12% |
20,263
-9,869
| -33% | -$416K |
|
|
KTWO
280
DELISTED
K2M Group Holdings, Inc
KTWO
| $761K | 0.12% |
40,899
-18,391
| -31% | -$402K |
|
|
NDRM
281
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $758K | 0.12% |
+36,686
| New | +$752K |
|
282
Marcus & Millichap
MMI
$1.16B
| $746K | 0.12% |
16,222
-9,687
| -37% | -$454K |
|
283
TherapeuticsMD
TXMD
$23.8M
| $734K | 0.12% |
2,505
-547
| -18% | -$194K |
|
284
Coherus Oncology
CHRS
$230M
| $715K | 0.11% |
+35,656
| New | +$1.08M |
|
|
ATTU
285
DELISTED
Attunity Ltd
ATTU
| $710K | 0.11% |
+51,963
| New | +$730K |
|
|
PMC
286
DELISTED
PharMerica Corporation
PMC
| $672K | 0.11% |
+23,595
| New | +$793K |
|
287
Repligen
RGEN
$8.32B
| $634K | 0.1% |
22,769
-50,679
| -69% | -$1.83M |
|
|
ALDR
288
DELISTED
Alder Biopharmaceuticals
ALDR
| $575K | 0.09% |
17,562
-4,812
| -22% | -$205K |
|
|
AVDL
289
DELISTED
Avadel Pharmaceuticals
AVDL
| $558K | 0.09% |
+34,213
| New | +$754K |
|
|
CPRX
290
DELISTED
Catalyst Pharmaceutical
CPRX
| $183K | 0.03% |
60,858
-170,193
| -74% | -$735K |
|
|
AGEN
291
Agenus
AGEN
$344M
| – | – |
-28,925
| Closed | -$4.9M |
|
292
Amphastar Pharmaceuticals
AMPH
$886M
| – | – |
-68,224
| Closed | -$1.2M |
|
293
Apogee Enterprises
APOG
$890M
| – | – |
-56,999
| Closed | -$3M |
|
294
Atara Biotherapeutics
ATRA
$79.5M
| – | – |
-717
| Closed | -$946K |
|
295
Astronics
ATRO
$3.75B
| – | – |
-83,458
| Closed | -$3.24M |
|
296
BK Technologies
BKTI
$304M
| – | – |
-46,252
| Closed | -$1.14M |
|
|
BLUE
297
DELISTED
bluebird bio
BLUE
| – | – |
-1,582
| Closed | -$3.45M |
|
|
298
Boot Barn
BOOT
$4.95B
| – | – |
-155,707
| Closed | -$4.98M |
|
299
Cal-Maine
CALM
$4B
| – | – |
-63,482
| Closed | -$3.31M |
|
300
Cohu
COHU
$2.48B
| – | – |
-95,973
| Closed | -$1.27M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
ICCFIA
WCM
EAM Investors's Q3 2015 Portfolio in Review
As of Q3 2015, EAM Investors held 416 positions worth $632M, down 26% from $855M the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
EAM Investors withdrew a net $201M in Q3 2015, closing 126 positions and reducing 134 holdings. Its most notable exit was Sigma Designs Inc, an estimated $8.78M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in Lipocine worth $4.07M.
- EAM Investors's largest Q3 2015 buy was Lipocine: 20,214 shares worth $4.07M.
- EAM Investors added most to Boingo Wireless, Inc. in Q3 2015, an estimated $3.32M increase.
- EAM Investors's biggest Q3 2015 reduction was NEOPHOTONICS CORP, cutting an estimated $4.34M.
- EAM Investors fully exited Sigma Designs Inc in Q3 2015, selling an estimated $8.78M.
- EAM Investors's ten largest holdings make up 7.7% of its $632M portfolio in Q3 2015.
- EAM Investors opened 106 new positions and closed 126 in Q3 2015.
- EAM Investors's portfolio value fell 26% quarter-over-quarter to $632M.
Based on EAM Investors's 13F filing for Q3 2015, filed 6 Nov 2015.